Insite supervised injection site receives Health Canada exemption

Advocates fear new federal legislation will make it harder to open safe injection sites in future

Canada’s first supervised injection site has received a Health Canada exemption that allows it to continue to operate, days after passage of federal legislation that critics fear will make it harder to open new facilities.

Vancouver Coastal Health is required to apply for an annual exemption to operate Insite.

“We know Insite works,” says Coastal Health chief medical health officer Dr. Patricia Daly, in a written statement.

“Thousands of overdose deaths have been prevented, the spread of infectious diseases like HIV and hepatitis C have been reduced, and clients can more easily connect to health services like detox and primary health care,” she says.

Landmark decision

The Conservative government is opposed to the Insite operation and has taken its fight with the supervised injection site to the Supreme Court of Canada.

In a landmark 2011 ruling, the court found that not allowing the clinic to operate would violate the Charter of Rights and Freedoms.

This week the government passed Bill C-2, the Respect for Communities Act.

Daly said the new legislation will make the process of applying for an exemption more onerous, requiring volumes of information to meet 27 conditions.

“VCH is troubled by the numerous conditions set out in the new legislation,” she said.

Donald MacPherson, spokesman for the Canadian Drug Policy Coalition, said he believes the government purposely created Bill C-2 to discourage new sites from opening

“Supervised consumption sites are a response to a very dire situation,” he said.

According to Coastal Health, more than 1.8 million injections have happened at Insite under the supervision of nurses. There have been no overdose deaths, and as many as 800 people visit the facility daily.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below